Autocrine regulation of collagenase 3 (matrix metalloproteinase 13) during osteoarthritis

Arthritis and Rheumatism

Volumn 43, Issue 1, 2000, Pages 195-205

  Shlopov, Boris V ^a   Gumanovskaya, Marina L ^b   Hasty, Karen A ^a,c  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b BD Technologies   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGENASE 3; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1BETA; MESSENGER RNA; RECEPTOR SUBUNIT; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; AUTOCRINE EFFECT; CARTILAGE CELL; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPATHOLOGY; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION;

AGED; AUTOCRINE COMMUNICATION; CHONDROCYTES; COLLAGENASES; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1; INTERLEUKIN-10; INTERLEUKIN-6; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 13; MATRIX METALLOPROTEINASES; MIDDLE AGED; OSTEOARTHRITIS; PHENOTYPE; RECEPTORS, INTERLEUKIN-1; RECEPTORS, INTERLEUKIN-1 TYPE II; RECEPTORS, INTERLEUKIN-6; RECEPTORS, TUMOR NECROSIS FACTOR; RNA, MESSENGER; SIALOGLYCOPROTEINS; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034092320     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(200001)43:1<195::AID-ANR24>3.0.CO;2-G     Document Type: Article

References (43)

1. Goldberg GI, Wilhelm SM, Kronberger A, Bauer EA, Grant GA, Eisen AZ. Human fibroblast collagenase: complete primary structure and homology to an oncogene transformation-induced rat protein. J Biol Chem 1986;261:6600-5.
2. Hasty KA, Pourmotabbed F, Goldberg GI, Thompson JP, Nelson RL, Spinella D, et al. Human neutrophil collagenase: a distinct gene product with homology to other matrix metalloproteinases. J Biol Chem 1990;265:11421-4.
3. Freije JM, DiezItza I, Balbin M, Sanchez LM, Blasco R, Tolivia J, et al. Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas. J Biol Chem 1994;269:16766-73.
4. Mitchell PG, Magna HA, Reeves LM, Lopresti-Morrow LL, Yocum SA, Rosner PJ, et al. Cloning, expression and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage. J Clin Invest 1996;97:761-8.
5. Borden P, Solymar D, Sucharczuk A, Lindman B, Cannon P, Heller RA. Cytokine control of interstitial collagenase and collagenase-3 gene expression in human chondrocytes. J Biol Chem 1996;271:23577-81.
6. Ståhle-Bäckahl M, Sandstedt B, Bruce K, Lindahl A, Jiménez MG, Vega JA, et al. Collagenase-3 (MMP-13) is expressed during human fetal ossification and re-expressed in postnatal bone remodeling and in rheumatoid arthritis. Lab Invest 1997;76:717-28.
7. Reboul P, Pelletier J-P, Tardif G, Cloutier J-M, Martel-Pelletier J. The new collagenase, collagenase-3, is expressed and synthesized by human chondrocytes but not by synoviocytes. J Clin Invest 1996;97:2011-9.
8. Shlopov BV, Lie W-R, Mainardi CL, Cole AA, Chubinskaya S, Hasty KA. Osteoarthritic lesions: involvement of three different collagenases. Arthritis Rheum 1997;40:2065-74.
9. Wernicke D, Seyfert C, Hinzmann B, Gromnica IE. Cloning of collagenase 3 from the synovial membrane and its expression in rheumatoid arthritis and osteoarthritis. J Rheumatol 1996;23: 590-5.
10. Lindy O, Konttinen YT, Sorsa T, Ding Y, Santavirtu S, Čeponis A, et al. Matrix metalloproteinase 13 (collagenase 3) in human rheumatoid synovium. Arthritis Rheum 1997;40:1391-9.
11. Shlopov BV, Smith GN Jr, Cole AA, Hasty KA. Differential patterns of response to doxycycline and transforming growth factor β1 in the down-regulation of collagenases in osteoarthritic and normal human chondrocytes. Arthritis Rheum 1999;42:719-27.
12. Chandrasekhar S, Harvey AK. Induction of interleukin-1 receptors on chondrocytes by fibroblast growth factor: a possible mechanism for modulation of interleukin-1 activity. J Cell Physiol 1989;138: 236-46.
13. Martel-Pelletier J, McCollum R, DiBattista J, Faure M-P, Chin JA, Fournier S. et al. The interleukin-1 receptor in normal and osteoarthritic human articular chondrocytes: identification as the type I receptor and analysis of binding kinetics and biologic function. Arthritis Rheum 1992;35:530-40.
14. Smith RJ, Justen JM, Sam LM, Rohloff NA, Ruppel PL, Brunden MN, et al. Platelet-derived growth factor potentiates cellular responses of articular chondrocytes to interleukin-1. Arthritis Rheum 1991;34:697-706.
15. Hrycaj P, Stratz T, Kovac C, Mennet P, Muller W. Microheterogeneity of acute phase proteins in patients with clinically active and clinically nonactive osteoarthritis. Clin Rheumatol 1995;14: 434-40.
16. Westacott CI, Atkins RM, Dieppe PA, Elson CJ. Tumor necrosis factor-alpha receptor expression on chondrocytes isolated from human articular cartilage. J Rheumatol 1994;21:1710-5.
17. Shinmei M, Masuda K, Kikuchi T, Shimomura Y, Okada Y. Production of cytokines by chondrocytes and its role in proteoglycan degradation. J Rheumatol Suppl 1991;27:89-91.
18. Bonewald LF, Mundy GR. Role of transforming growth factor-beta in bone remodeling. Clin Orthop 1990;261-76.
19. Wozney JM, Rosen V, Byrne M, Celeste AJ, Moutsatsos I, Wang EA. Growth factors influencing bone development. J Cell Sci 1990;13 Suppl:149-56.
20. Bonewald LF, Dallas SL. Role of active and latent transforming growth factor beta in bone formation. J Cell Biochem 1994;55: 350-7.
21. Linkhart TA, Mohan S, Baylink DJ. Growth factors for bone growth and repair: IGF, TGF beta and BMP. Bone 1996;19 Suppl 1:1S-2S.
22. Cameron ML, Fu FH, Paessler HH, Schneider M, Evans CH. Synovial fluid cytokine concentrations as possible prognostic indicators in the ACL-deficient knee. Knee Surg Sports Traumatol Arthrose 1994;2:38-44.
23. Fawthrop FW, Frazer A, Russell RG, Bunning RA. Effects of transforming growth factor beta on the production of prostaglandin E and caseinase activity of unstimulated and interleukin 1-stimulated human articular chondrocytes in culture. Br J Rheumatol 1997;36:729-34.
24. Brinckerhoff CE, Sirum CK, Karmilowicz MJ, Auble DT. Expression of stromelysin and stromelysin-2 in rabbit and human fibroblasts. Matrix 1992;1 Suppl:165-75.
25. Kammermann JR, Kincaid SA, Rumph PF, Baird DK, Visco DM. Tumor necrosis factor-alpha (TNF-alpha) in canine osteoarthritis: immunolocalization of TNF-alpha, stromelysin and TNF receptors in canine osteoarthritic cartilage. Osteoarthritis Cartilage 1996;4: 23-34.
26. Callaghan MM, Lovis RM, Rammohan C, Lu Y, Pope RM. Autocrine regulation of collagenase gene expression by TNF-alpha in U937 cells. J Leukoc Biol 1996;59:125-32.
27. Mac NK, Chartrain N, Lark M, Tocci MJ, Hutchinson NI. Discoordinate expression of stromelysin, collagenase, and tissue inhibitor of metalloproteinases-1 in rheumatoid human synovial fibroblasts: synergistic effects of interleukin-1 and tumor necrosis factor-alpha on stromelysin expression. J Biol Chem 1990;265: 17238-45.
28. Villiger PM, Kusari AB, ten Dijke P, Lotz M. IL-1β and IL-6 selectively induce transforming growth factor-β isoforms in human articular chondrocytes. J Immunol 1993;151:3337-44.
29. Lotz M, Blanco FJ, von Kempis J, Dudler J, Maier R, Villiger PM, et al. Cytokine regulation of chondrocyte functions. J Rheumatol Suppl 1995;43:104-8.
30. Reitamo S, Remitz A, Tamai K, Uitto J. Interleukin-10 modulates type I collagen and matrix metalloprotease gene expression in cultured human skin fibroblasts. J Clin Invest 1994;94:2489-92.
31. Mertz PM, De Witt DL, Stetler-Stevenson WG, Wahl LM. Interleukin 10 suppression of monocyte prostaglandin H synthase-2: mechanism of inhibition of prostaglandin-dependent matrix metalloproteinase production. J Biol Chem 1994;269:21322-9.
32. Webb GR, Westacott CI, Elson CJ. Osteoarthritic synovial fluid and synovium supernatants up-regulate tumor necrosis factor receptors on human articular chondrocytes. Osteoarthritis Cartilage 1998;6:167-76.
33. Pasparakis M, Alexopoulou L, Episkopou V, Kollias G. Immune and inflammatory responses in TNF alpha-deficient mice: a critical requirement for TNF alpha in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response. J Exp Med 1996;184:1397-411.
34. Le Hir M, Bluethmann H, Kosco-Vilbois MH, Muller M, Di Padova F, Moore M, et al. Differentiation of follicular dendritic cells and full antibody responses require tumor necrosis factor receptor-1 signaling. J Exp Med 1996;183:2367-72.
35. Pfeffer K, Matsuyama T, Kundig TM, Wakeham A, Kishihara K, Shahinian A, et al. Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell 1993;73:457-67.
36. Neumann B, Machleidt T, Lifka A, Wakeham A, Kishihara K, Shahinian A, et al. Crucial role of 55-kilodalton TNF receptor in TNF-induced adhesion molecule expression and leukocyte organ infiltration. J Immunol 1996;156:1587-93.
37. Rothe J, Lesslauer W, Lotscher H, Lang Y, Koebel P, Kontgen F, et al. Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature 1993;364:798-802.
38. Ruby J, Bluethmann H, Peschon JJ. Antiviral activity of tumor necrosis factor (TNF) is mediated via p55 and p75 TNF receptors. J Exp Med 1997;186:1591-6.
39. Tartaglia LA, Weber RF, Reynolds IS, Palladino MA, Goeddel DV. The two different receptors for tumor necrosis factor mediate distinct cellular responses. Proc Natl Acad Sci U S A 1991;88: 9292-6.
40. Morales TI, Joyce ME, Sobel ME, Danielpour D, Roberts AB. Transforming growth factor-beta in calf articular cartilage organ cultures: synthesis and distribution. Arch Biochem Biophys 1991; 288:397-405.
41. Pedrozo HA, Schwartz Z, Gomez R, Ornoy A, Xin-Sheng W, Dallas SL, et al. Growth plate chondrocytes store latent transforming growth factor (TGF) beta 1 in their matrix through latent TGF-beta 1 binding protein-1. J Cell Physiol 1998;177:343-54.
42. Rédini F, Mauviel A, Pronost S, Loyau G, Pujol J-P. Transforming growth factor β exerts opposite effects from interleukin-1β on cultured rabbit articular chondrocytes through reduction of interleukin-1 receptor expression. Arthritis Rheum 1993;36:44-50.
43. Günther M, Haubeck H-D, van de Leur E, Bläser J, Bender S, Gütgemann I, et al. Transforming growth factor β1 regulates tissue inhibitor of metalloproteinases 1 expression in differentiated human articular chondrocytes. Arthritis Rheum 1994;37:395-405.